dc.contributor.author | Saglam, Esra Kaytan | |
dc.contributor.author | Sanli, Yasemin | |
dc.contributor.author | Yilmaz, Ebru | |
dc.contributor.author | Kuyumcu, Serkan | |
dc.contributor.author | Vatankulu, Betül | |
dc.contributor.author | Purisa, Sevim | |
dc.contributor.author | Adalet, Isik | |
dc.contributor.author | Ozkan, Zeynep Gozde | |
dc.date.accessioned | 2021-03-03T13:55:26Z | |
dc.date.available | 2021-03-03T13:55:26Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Vatankulu B., Sanli Y., Saglam E. K. , Kuyumcu S., Ozkan Z. G. , Yilmaz E., Purisa S., Adalet I., "Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?", MOLECULAR IMAGING AND RADIONUCLIDE THERAPY, cilt.24, sa.3, ss.120-127, 2015 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_36d7d388-5e06-4345-ad09-c35243af28fa | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/41000 | |
dc.identifier.uri | https://doi.org/10.4274/mirt.36744 | |
dc.description.abstract | Objective: We aimed to investigate the SUVmax of primary tumor and metastatic lymph node in predicting survival in patients with esophageal cancer. | |
dc.language.iso | eng | |
dc.subject | Tıp | |
dc.subject | Nükleer Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | RADYOLOJİ, NÜKLEER TIP ve MEDİKAL GÖRÜNTÜLEME | |
dc.title | Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer? | |
dc.type | Makale | |
dc.relation.journal | MOLECULAR IMAGING AND RADIONUCLIDE THERAPY | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 24 | |
dc.identifier.issue | 3 | |
dc.identifier.startpage | 120 | |
dc.identifier.endpage | 127 | |
dc.contributor.firstauthorID | 102245 | |